Actively Recruiting
A Prospective Study on the Use of an App (PancreasPlus) for Home Monitoring and Proactive Management of Patients With Pancreatic Cancer
Led by Casa di Cura Dott. Pederzoli · Updated on 2026-05-11
185
Participants Needed
2
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Caring for people with pancreatic cancer requires good coordination between hospital and home care, involving various healthcare professionals and active patient participation. This research evaluates the PancreasPlus app, designed to support patients and caregivers with information, self-monitoring tools, and communication with healthcare teams. The study aims to assess the app’s feasibility, patient engagement, perceived quality of care, and its impact on anxiety and unplanned hospital visits over a 3-month period. Participants will use the PancreasPlus app for about 3 months. The app helps track symptoms, weight, appointments, and provides educational content on nutrition, emotional support, and patient rights. Patients complete questionnaires about their physical and psychological wellbeing, including anxiety and quality of life. The app may suggest contacting healthcare providers if warning signs appear but does not replace medical decisions. Participants receive training and support to use the app, with possible reminder calls. During the study, participants complete initial assessments at the start and follow-up questionnaires at 12 weeks using the app. Data collected includes unplanned hospital visits, chemotherapy adherence, anxiety levels, nutritional status, quality of life, and app usability. Most activities are conducted remotely, supporting easy engagement. The study monitors patient involvement through questionnaire completion and satisfaction with the app, aiming to improve care coordination and patient experience.
CONDITIONS
Brief Title
Patients With Pancreatic Tumor: Use of an App to Monitor Progress in a Simple and Intuitive Way by Periodically Completing Targeted Questionnaires and Providing Educational and Informational Content (PancreasPlus).
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older with a diagnosis of pancreatic cancer confirmed by biopsy or cytology
- Access to a smartphone or tablet with internet connection
- Basic digital skills or caregiver support available
- Ability to understand and provide informed consent
- Understanding of the Italian language
You will not qualify if you...
- Severe uncompensated cognitive impairment
- Social or logistical issues preventing follow-up or app use
- Refusal or withdrawal of consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) to confirm eligibility and obtain consent
Duration - Approximately 3 months
Participants use the PancreasPlus app for approximately 3 months to monitor symptoms, weight, and wellbeing. They complete short questionnaires on physical and psychological health and access educational content. Reminder calls may be made during this period.
Initial visit to receive instructions and download the app; ongoing remote app use with periodic questionnaires
Trial Site Locations
Total: 2 locations
1
U.O. Chirurgia Generale 1, IRCCS San Matteo, Università degli Studi di Pavia
Pavia, Pavia, Italy, 27100
Active, Not Recruiting
2
Ospedale P. Pederzoli Casa di Cura Privata S.p.A.
Peschiera del Garda, Verona, Italy, 37019
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here